U.S. market Closed. Opens in 17 hours 7 minutes

SLRX | Salarius Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/A1.84M5.23M3.47M838.00K1.27M1.01MN/A
Cost of Revenue10.05K6.68K19.18K6.91K4.02K431.00K506.53K662.75KN/A
Gross Profit-10.05K-6.68K1.82M5.23M3.46M407.00K767.97K347.92KN/A
Operating Expenses12.88M22.98M14.65M12.84M11.73M22.48M35.49M40.23M29.21M
Selling, General & Admin5.71M7.14M6.10M6.11M7.71M10.57M18.50M19.86M16.46M
Research & Development7.17M15.84M8.55M6.91M4.02M11.91M16.99M20.38M12.75M
Other Operating ExpensesN/A8.87M-4.00-178.59KN/AN/AN/AN/AN/A
Operating Income-12.89M-31.84M-12.81M-7.79M-9.58M-22.07M-34.73M-39.89M-29.21M
Other Expenses / Income352.25K233.18K44.70K434.09K2.64M152.01K291.96K393.11K72.03K
Before Tax Income-12.54M-31.61M-12.77M-7.35M-6.94M-21.92M-34.43M-39.49M-29.14M
Income Tax Expenses-1.00-233.18K-63.88K-255.50K-1.33M152.01KN/AN/AN/A
Net Income-12.54M-31.37M-12.70M-7.10M-5.61M-21.92M-34.43M-39.49M-29.14M
Interest ExpensesN/A-233.18KN/A-3.05KN/AN/AN/AN/AN/A
Basic Shares Outstanding408.08K2.12M1.65M623.14K130.75K28.83K27.62K649.36K561.32K
Diluted Shares Outstanding408.08K2.12M1.65M623.14K130.75K28.83K27.62K649.36K561.32K
EBITDA-12.88M-14.12M-12.86M-7.85M-9.45M-22.07M-34.11M-39.22M-29.16M
EBITDA Margin0.00%0.00%-698.70%-149.97%-272.69%-2,634.13%-2,676.28%-3,880.21%0.00%
EBIT-12.54M-31.84M-12.77M-7.36M-6.94M-21.77M-34.43M-39.49M-29.14M
EBIT Margin0.00%0.00%-693.84%-140.55%-200.23%-2,597.85%-2,701.74%-3,907.65%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙